August 8, 2018 Press Releases

Statement on CMS Medicare Advantage Policy Change

WASHINGTON, DC — In light of the news that CMS will empower Medicare Advantage plans to negotiate for Part B drugs by using step therapy, Patients For Affordable Drugs President and Founder David Mitchell issued the following statement:

“I appreciate Secretary Azar’s work to curb rising drug prices. Today’s action to give Medicare Advantage plans greater leverage in negotiations with drug corporations is a small but positive step in Part B. As a patient, I understand concerns about the potential misuse of step therapy, but as long as patients are protected with a timely and workable appeals process, allowing step therapy in Medicare Advantage is a step I can support. I hope that moving forward, announcements will lower list prices and generate greater savings than today’s news.”



Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.